nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis
|
van Nooten, Floortje |
|
2017 |
39 |
4 |
p. 787-803.e18 8.03E20 p. |
artikel |
2 |
Changes in Asthma Maintenance Therapy Prescribing Patterns Following the 2006 Long-acting β-Agonist FDA Drug Warning
|
Winter, Jonathan D. |
|
2017 |
39 |
4 |
p. 697-701 5 p. |
artikel |
3 |
Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons
|
Wolf, Douglas |
|
2017 |
39 |
4 |
p. 849-862.e6 8.61999152E8 p. |
artikel |
4 |
Confounding Variables and the Performance of Triggers in Detecting Unreported Adverse Drug Reactions
|
Varallo, Fabiana Rossi |
|
2017 |
39 |
4 |
p. 686-696 11 p. |
artikel |
5 |
Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan
|
Nishie, Akihiro |
|
2017 |
39 |
4 |
p. 738-750.e4 7.499263E6 p. |
artikel |
6 |
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain
|
Villa, Guillermo |
|
2017 |
39 |
4 |
p. 771-786.e3 785230 p. |
artikel |
7 |
Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention
|
Earnshaw, Stephanie R. |
|
2017 |
39 |
4 |
p. 804-818.e3 817197 p. |
artikel |
8 |
Editorial Board
|
|
|
2017 |
39 |
4 |
p. A2- 1 p. |
artikel |
9 |
Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial
|
Nakamura, Masakazu |
|
2017 |
39 |
4 |
p. 863-872 10 p. |
artikel |
10 |
Frequency and Impact of Pharmacist Interventions in Clinical Trial Patients With Diabetes
|
Martinez, Joe |
|
2017 |
39 |
4 |
p. 714-722 9 p. |
artikel |
11 |
In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis
|
Hu, Jiali |
|
2017 |
39 |
4 |
p. 828-836 9 p. |
artikel |
12 |
Masthead
|
|
|
2017 |
39 |
4 |
p. A3- 1 p. |
artikel |
13 |
Opportunities for Collaboration at the Interface of Pharmacovigilance and Manufacturing
|
Beninger, Paul |
|
2017 |
39 |
4 |
p. 702-712 11 p. |
artikel |
14 |
Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment
|
Eliasson, Lina |
|
2017 |
39 |
4 |
p. 723-737 15 p. |
artikel |
15 |
Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment
|
Christopher, Ronald J. |
|
2017 |
39 |
4 |
p. 837-848.e7 8.479999164E9 p. |
artikel |
16 |
Postmarketing Surveillance Studies—An Industry Perspective on Changing Global Requirements and Implications
|
Haque, Arshadul |
|
2017 |
39 |
4 |
p. 675-685 11 p. |
artikel |
17 |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin
|
Cui, Na |
|
2017 |
39 |
4 |
p. 751-758 8 p. |
artikel |
18 |
Risk Communication in a Pharmacovigilance Environment
|
Beninger, Paul |
|
2017 |
39 |
4 |
p. 672-674 3 p. |
artikel |
19 |
Risk Evaluation and Mitigation Strategies (REMS), Pemoline, and What Is a Signal?
|
Shader, Richard I. |
|
2017 |
39 |
4 |
p. 665-669 5 p. |
artikel |
20 |
Table of Contents
|
|
|
2017 |
39 |
4 |
p. A4-A5 nvt p. |
artikel |
21 |
Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study
|
Overbeek, Jetty A. |
|
2017 |
39 |
4 |
p. 759-770 12 p. |
artikel |
22 |
Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands
|
Kuiper, Josephina G. |
|
2017 |
39 |
4 |
p. 819-827.e1 7452 p. |
artikel |